Suchergebnisse - "Guan, Yanfang"

PubPharm (8)

1

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients

enthalten in: Cancer medicine | 2022

von Liu, B. | Yi, Z. | Guan, Y. | +10

2

Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer

enthalten in: Nature communications | 2021

von Zhou, H. | Hu, Y. | Luo, R. | +25

3

Oncogenic mutations within the β3-αC loop of EGFR/ERBB2/BRAF/MAP2K1 predict response to therapies

enthalten in: Molecular genetics & genomic medicine | 2020

von Zhang, B. | Chen, Y. | Dai, P. | +12

4

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

enthalten in: International journal of cancer | 2020

von Ma, F. | Guan, Y. | Yi, Z. | +16

ErratumIn: Int J Cancer. 2020 Jun 15;146(12):E8. - PMID 32320496

5

Co-mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancer

enthalten in: Journal of cellular and molecular medicine | 2019

von Xing, P. | Han, X. | Wang, S. | +14

6

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer

enthalten in: EBioMedicine | 2019

von Wang, Y. | Zhao, C. | Chang, L. | +12

7

ctDNA dynamics : a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy

enthalten in: Oncotarget | 2016

von Ma, F. | Zhu, W. | Guan, Y. | +9

8

A recurrent PDGFRB mutation causes familial infantile myofibromatosis

enthalten in: American journal of human genetics | 2013

von Cheung, Y. | Gayden, T. | Campeau, P. | +22

CommentIn: Clin Genet. 2013 Oct;84(4):340-1. - PMID 23865785

1
[1]